Bryan Johnson· Author
Durability: The positive effect was still as strong on Day 3 post-dose as it was on Day 1.
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Durability: The positive effect was still as strong on Day 3 post-dose as it was on Day 1.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
First documented human CGM-based observation of improved post-psilocybin glucose control.
Durability: The positive effect was still as strong on Day 3 post-dose as it was on Day 1. Note: A long trip to China on Day 4 interrupted this streak. We plan to explore the full durability of this effect with the next dose.
This single session reduced my estimated HbA1c 0.3 6.8% from 4.7% to 4.4%, (a relative reduction of 6.8%).